Clinical Trial Update: Study of INS365 Ophthalmic Solution in Subjects With Dry Eye Disease [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating INS365 Ophthalmic Solution in subjects with dry eye disease has completed. The update does not report trial outcomes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease

Drugs mentioned

• INS365 Ophthalmic Solution (INS365)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Dry Eye Disease | Phase 3 | Status: COMPLETED